Literature DB >> 16225356

Dying dementia patients: too much suffering, too little palliation.

Bechor Zvi Aminoff1, Abraham Adunsky.   

Abstract

Patient suffering is a pathological syndrome traditionally viewed as encompassing psychological distress, spiritual concerns, and various aspects of physical pain. There is insufficient clinical evidence for suffering in dying dementia patients, which may lead to inappropriate evaluation and insufficient palliative treatment. Our objective was to evaluate the suffering of terminal dementia patients over time, from admission to a geriatric ward to the last day of life. The study included consecutive end-stage dementia patients in a general geriatric department of a tertiary hospital. Patients were evaluated weekly by the Mini Suffering State Examination scale (MSSE) which measures many domains related to suffering. Seventy-one patients were studied. Mean survival of patients was 38.0 +/- 5.1 days. MSSE increased during hospital stay from 5.62 +/- 2.31 to 6.89 +/- 1.95 (p < 0.001). According to MSSE scale, 63.4 percent and 29.6 percent of patients died with a high and intermediate level of suffering, respectively. Only 7 percent of the patients died with a low level of suffering. In particular, patients were restless (p < 0. 001), had pressure sores (p = 0.01), and were considered medically unstable (p < 0.001). We concluded that, despite traditional medical and nursing care, a large proportion of dying dementia patients experience an increasing amount of suffering as they approach death. New palliative treatment approaches should be developed for these patients.

Entities:  

Mesh:

Year:  2005        PMID: 16225356     DOI: 10.1177/104990910502200507

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  9 in total

Review 1.  Pitfalls in imaging the frail elderly.

Authors:  R Fawcett; P McCoubrie
Journal:  Br J Radiol       Date:  2015-01       Impact factor: 3.039

2.  Advanced dementia: state of the art and priorities for the next decade.

Authors:  Susan L Mitchell; Betty S Black; Mary Ersek; Laura C Hanson; Susan C Miller; Greg A Sachs; Joan M Teno; R Sean Morrison
Journal:  Ann Intern Med       Date:  2012-01-03       Impact factor: 25.391

3.  Dying with dementia: symptom burden, quality of care, and place of death.

Authors:  Luis Carlos Escobar Pinzon; Matthias Claus; Klaus Maria Perrar; Kirsten Isabel Zepf; Stephan Letzel; Martin Weber
Journal:  Dtsch Arztebl Int       Date:  2013-03-22       Impact factor: 5.594

4.  Quality of hospice care for individuals with dementia.

Authors:  Jennifer S Albrecht; Ann L Gruber-Baldini; Erik K Fromme; Jessina C McGregor; David S H Lee; Jon P Furuno
Journal:  J Am Geriatr Soc       Date:  2013-05-27       Impact factor: 5.562

5.  The clinical course of advanced dementia.

Authors:  Susan L Mitchell; Joan M Teno; Dan K Kiely; Michele L Shaffer; Richard N Jones; Holly G Prigerson; Ladislav Volicer; Jane L Givens; Mary Beth Hamel
Journal:  N Engl J Med       Date:  2009-10-15       Impact factor: 91.245

Review 6.  Percutaneous endoscopic gastrostomy: indications, technique, complications and management.

Authors:  Ata A Rahnemai-Azar; Amir A Rahnemaiazar; Rozhin Naghshizadian; Amparo Kurtz; Daniel T Farkas
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

7.  Practice of end-of-life care for patients with advanced dementia by hospital physicians and nurses: Comparison between medical and surgical wards.

Authors:  Meira Erel; Esther-Lee Marcus; Freda Dekeyser-Ganz
Journal:  Dementia (London)       Date:  2022-03-28

Review 8.  Hospital outcomes of older people with cognitive impairment: An integrative review.

Authors:  Carole Fogg; Peter Griffiths; Paul Meredith; Jackie Bridges
Journal:  Int J Geriatr Psychiatry       Date:  2018-06-26       Impact factor: 3.485

9.  End Stage Clinical Features and Cause of Death of Behavioral Variant Frontotemporal Dementia and Young-Onset Alzheimer's Disease.

Authors:  Marie-Paule E van Engelen; Flora T Gossink; Lieke S de Vijlder; Jan R A Meursing; Philip Scheltens; Annemiek Dols; Yolande A L Pijnenburg
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.